Article
In vivo evolution of resistant subpopulations of KPC-producing Klebsiella pneumoniae during ceftazidime/avibactam treatment.
The Journal of antimicrobial chemotherapy - 1 Jun 2018
Gaibani Paolo, Campoli Caterina, Lewis Russell E, Volpe Silvia Lidia, Scaltriti Erika, Giannella Maddalena, Pongolini Stefano, Berlingeri Andrea, Cristini Francesco, Bartoletti Michele, Tedeschi Sara, Ambretti Simone
Abstract excerpt
Objectives: KPC-producing Klebsiella pneumoniae (KPC-Kp) represent a serious problem worldwide. Herein, we describe the evolution of ceftazidime/avibactam resistance by sequencing longitudinal clinical isolates from a patient with KPC-Kp bloodstream infection undergoing ceftazidime/avibactam treatment. Methods: WGS was performed on one ceftazidime/avibactam-susceptible KPC-Kp (BOT-CA-S) and two phenotypically...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
